|Send to printer »|
9 Ways to Optimize Preclinical Imaging
These tips can help drug developers design and monitor clinical trials, bringing drugs to market faster.!--h2>
Preclinical models and the modalities used within them are tools to study certain aspects of disease, such as neurodegeneration in diseases of the central nervous system. Following are tips to ensure imaging in a preclinical space generates more translatable data across all disease states, helping drug developers better design and monitor clinical trials and bring drugs to market faster.
Patrick Sweeney is managing director at Charles River Laboratories.
© 2013 Genetic Engineering & Biotechnology News, All Rights Reserved